Global Macular Degeneration Treatment Market Growth (Status and Outlook) 2025-2031
According to this study, the global Macular Degeneration Treatment market size will reach US$ 8270 million by 2031.
Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Macular Degeneration Treatment Industry Forecast” looks at past sales and reviews total world Macular Degeneration Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Macular Degeneration Treatment sales for 2025 through 2031. With Macular Degeneration Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Macular Degeneration Treatment industry.
This Insight Report provides a comprehensive analysis of the global Macular Degeneration Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Macular Degeneration Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Macular Degeneration Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Macular Degeneration Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Macular Degeneration Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Macular Degeneration Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
Macular degeneration, also known as age-related macular degeneration (AMD or ARMD), is a medical condition which may result in blurred or no vision in the center of the visual field. Early on there are often no symptoms. Over time, however, some people experience a gradual worsening of vision that may affect one or both eyes. While it does not result in complete blindness, loss of central vision can make it hard to recognize faces, drive, read, or perform other activities of daily life. Visual hallucinations may also occur but these do not represent a mental illness.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
LPI (LP Information)' newest research report, the “Macular Degeneration Treatment Industry Forecast” looks at past sales and reviews total world Macular Degeneration Treatment sales in 2024, providing a comprehensive analysis by region and market sector of projected Macular Degeneration Treatment sales for 2025 through 2031. With Macular Degeneration Treatment sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Macular Degeneration Treatment industry.
This Insight Report provides a comprehensive analysis of the global Macular Degeneration Treatment landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Macular Degeneration Treatment portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Macular Degeneration Treatment market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Macular Degeneration Treatment and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Macular Degeneration Treatment.
This report presents a comprehensive overview, market shares, and growth opportunities of Macular Degeneration Treatment market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Lucentis
- Eylea
- Avastin
- Others
- Hospitals
- Eye Clinics
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Bausch Health Companies
- Allergan
- Novartis
- Pfizer
- Bayer
- Roche
- Sanofi
- Santen Pharmaceuticals
- Regeneron Pharmaceuticals
- Kanghong Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Macular Degeneration Treatment Market Size (2020-2031)
2.1.2 Macular Degeneration Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Macular Degeneration Treatment by Country/Region (2020, 2024 & 2031)
2.2 Macular Degeneration Treatment Segment by Type
2.2.1 Lucentis
2.2.2 Eylea
2.2.3 Avastin
2.2.4 Others
2.3 Macular Degeneration Treatment Market Size by Type
2.3.1 Macular Degeneration Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
2.4 Macular Degeneration Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Eye Clinics
2.4.3 Others
2.5 Macular Degeneration Treatment Market Size by Application
2.5.1 Macular Degeneration Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
3 MACULAR DEGENERATION TREATMENT MARKET SIZE BY PLAYER
3.1 Macular Degeneration Treatment Market Size Market Share by Player
3.1.1 Global Macular Degeneration Treatment Revenue by Player (2020-2025)
3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Macular Degeneration Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MACULAR DEGENERATION TREATMENT BY REGION
4.1 Macular Degeneration Treatment Market Size by Region (2020-2025)
4.2 Global Macular Degeneration Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Macular Degeneration Treatment Market Size Growth (2020-2025)
4.4 APAC Macular Degeneration Treatment Market Size Growth (2020-2025)
4.5 Europe Macular Degeneration Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Macular Degeneration Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Macular Degeneration Treatment Market Size by Country (2020-2025)
5.2 Americas Macular Degeneration Treatment Market Size by Type (2020-2025)
5.3 Americas Macular Degeneration Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Macular Degeneration Treatment Market Size by Region (2020-2025)
6.2 APAC Macular Degeneration Treatment Market Size by Type (2020-2025)
6.3 APAC Macular Degeneration Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Macular Degeneration Treatment Market Size by Country (2020-2025)
7.2 Europe Macular Degeneration Treatment Market Size by Type (2020-2025)
7.3 Europe Macular Degeneration Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Macular Degeneration Treatment by Region (2020-2025)
8.2 Middle East & Africa Macular Degeneration Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Macular Degeneration Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MACULAR DEGENERATION TREATMENT MARKET FORECAST
10.1 Global Macular Degeneration Treatment Forecast by Region (2026-2031)
10.1.1 Global Macular Degeneration Treatment Forecast by Region (2026-2031)
10.1.2 Americas Macular Degeneration Treatment Forecast
10.1.3 APAC Macular Degeneration Treatment Forecast
10.1.4 Europe Macular Degeneration Treatment Forecast
10.1.5 Middle East & Africa Macular Degeneration Treatment Forecast
10.2 Americas Macular Degeneration Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Macular Degeneration Treatment Forecast
10.2.2 Canada Market Macular Degeneration Treatment Forecast
10.2.3 Mexico Market Macular Degeneration Treatment Forecast
10.2.4 Brazil Market Macular Degeneration Treatment Forecast
10.3 APAC Macular Degeneration Treatment Forecast by Region (2026-2031)
10.3.1 China Macular Degeneration Treatment Market Forecast
10.3.2 Japan Market Macular Degeneration Treatment Forecast
10.3.3 Korea Market Macular Degeneration Treatment Forecast
10.3.4 Southeast Asia Market Macular Degeneration Treatment Forecast
10.3.5 India Market Macular Degeneration Treatment Forecast
10.3.6 Australia Market Macular Degeneration Treatment Forecast
10.4 Europe Macular Degeneration Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Macular Degeneration Treatment Forecast
10.4.2 France Market Macular Degeneration Treatment Forecast
10.4.3 UK Market Macular Degeneration Treatment Forecast
10.4.4 Italy Market Macular Degeneration Treatment Forecast
10.4.5 Russia Market Macular Degeneration Treatment Forecast
10.5 Middle East & Africa Macular Degeneration Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Macular Degeneration Treatment Forecast
10.5.2 South Africa Market Macular Degeneration Treatment Forecast
10.5.3 Israel Market Macular Degeneration Treatment Forecast
10.5.4 Turkey Market Macular Degeneration Treatment Forecast
10.6 Global Macular Degeneration Treatment Forecast by Type (2026-2031)
10.7 Global Macular Degeneration Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Macular Degeneration Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Information
11.1.2 Bausch Health Companies Macular Degeneration Treatment Product Offered
11.1.3 Bausch Health Companies Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bausch Health Companies Main Business Overview
11.1.5 Bausch Health Companies Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Macular Degeneration Treatment Product Offered
11.2.3 Allergan Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Macular Degeneration Treatment Product Offered
11.3.3 Novartis Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Macular Degeneration Treatment Product Offered
11.4.3 Pfizer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Macular Degeneration Treatment Product Offered
11.5.3 Bayer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Macular Degeneration Treatment Product Offered
11.6.3 Roche Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Macular Degeneration Treatment Product Offered
11.7.3 Sanofi Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Santen Pharmaceuticals
11.8.1 Santen Pharmaceuticals Company Information
11.8.2 Santen Pharmaceuticals Macular Degeneration Treatment Product Offered
11.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Santen Pharmaceuticals Main Business Overview
11.8.5 Santen Pharmaceuticals Latest Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Information
11.9.2 Regeneron Pharmaceuticals Macular Degeneration Treatment Product Offered
11.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Regeneron Pharmaceuticals Main Business Overview
11.9.5 Regeneron Pharmaceuticals Latest Developments
11.10 Kanghong Pharma
11.10.1 Kanghong Pharma Company Information
11.10.2 Kanghong Pharma Macular Degeneration Treatment Product Offered
11.10.3 Kanghong Pharma Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Kanghong Pharma Main Business Overview
11.10.5 Kanghong Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Macular Degeneration Treatment Market Size (2020-2031)
2.1.2 Macular Degeneration Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for Macular Degeneration Treatment by Country/Region (2020, 2024 & 2031)
2.2 Macular Degeneration Treatment Segment by Type
2.2.1 Lucentis
2.2.2 Eylea
2.2.3 Avastin
2.2.4 Others
2.3 Macular Degeneration Treatment Market Size by Type
2.3.1 Macular Degeneration Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
2.4 Macular Degeneration Treatment Segment by Application
2.4.1 Hospitals
2.4.2 Eye Clinics
2.4.3 Others
2.5 Macular Degeneration Treatment Market Size by Application
2.5.1 Macular Degeneration Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
3 MACULAR DEGENERATION TREATMENT MARKET SIZE BY PLAYER
3.1 Macular Degeneration Treatment Market Size Market Share by Player
3.1.1 Global Macular Degeneration Treatment Revenue by Player (2020-2025)
3.1.2 Global Macular Degeneration Treatment Revenue Market Share by Player (2020-2025)
3.2 Global Macular Degeneration Treatment Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 MACULAR DEGENERATION TREATMENT BY REGION
4.1 Macular Degeneration Treatment Market Size by Region (2020-2025)
4.2 Global Macular Degeneration Treatment Annual Revenue by Country/Region (2020-2025)
4.3 Americas Macular Degeneration Treatment Market Size Growth (2020-2025)
4.4 APAC Macular Degeneration Treatment Market Size Growth (2020-2025)
4.5 Europe Macular Degeneration Treatment Market Size Growth (2020-2025)
4.6 Middle East & Africa Macular Degeneration Treatment Market Size Growth (2020-2025)
5 AMERICAS
5.1 Americas Macular Degeneration Treatment Market Size by Country (2020-2025)
5.2 Americas Macular Degeneration Treatment Market Size by Type (2020-2025)
5.3 Americas Macular Degeneration Treatment Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Macular Degeneration Treatment Market Size by Region (2020-2025)
6.2 APAC Macular Degeneration Treatment Market Size by Type (2020-2025)
6.3 APAC Macular Degeneration Treatment Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Macular Degeneration Treatment Market Size by Country (2020-2025)
7.2 Europe Macular Degeneration Treatment Market Size by Type (2020-2025)
7.3 Europe Macular Degeneration Treatment Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Macular Degeneration Treatment by Region (2020-2025)
8.2 Middle East & Africa Macular Degeneration Treatment Market Size by Type (2020-2025)
8.3 Middle East & Africa Macular Degeneration Treatment Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL MACULAR DEGENERATION TREATMENT MARKET FORECAST
10.1 Global Macular Degeneration Treatment Forecast by Region (2026-2031)
10.1.1 Global Macular Degeneration Treatment Forecast by Region (2026-2031)
10.1.2 Americas Macular Degeneration Treatment Forecast
10.1.3 APAC Macular Degeneration Treatment Forecast
10.1.4 Europe Macular Degeneration Treatment Forecast
10.1.5 Middle East & Africa Macular Degeneration Treatment Forecast
10.2 Americas Macular Degeneration Treatment Forecast by Country (2026-2031)
10.2.1 United States Market Macular Degeneration Treatment Forecast
10.2.2 Canada Market Macular Degeneration Treatment Forecast
10.2.3 Mexico Market Macular Degeneration Treatment Forecast
10.2.4 Brazil Market Macular Degeneration Treatment Forecast
10.3 APAC Macular Degeneration Treatment Forecast by Region (2026-2031)
10.3.1 China Macular Degeneration Treatment Market Forecast
10.3.2 Japan Market Macular Degeneration Treatment Forecast
10.3.3 Korea Market Macular Degeneration Treatment Forecast
10.3.4 Southeast Asia Market Macular Degeneration Treatment Forecast
10.3.5 India Market Macular Degeneration Treatment Forecast
10.3.6 Australia Market Macular Degeneration Treatment Forecast
10.4 Europe Macular Degeneration Treatment Forecast by Country (2026-2031)
10.4.1 Germany Market Macular Degeneration Treatment Forecast
10.4.2 France Market Macular Degeneration Treatment Forecast
10.4.3 UK Market Macular Degeneration Treatment Forecast
10.4.4 Italy Market Macular Degeneration Treatment Forecast
10.4.5 Russia Market Macular Degeneration Treatment Forecast
10.5 Middle East & Africa Macular Degeneration Treatment Forecast by Region (2026-2031)
10.5.1 Egypt Market Macular Degeneration Treatment Forecast
10.5.2 South Africa Market Macular Degeneration Treatment Forecast
10.5.3 Israel Market Macular Degeneration Treatment Forecast
10.5.4 Turkey Market Macular Degeneration Treatment Forecast
10.6 Global Macular Degeneration Treatment Forecast by Type (2026-2031)
10.7 Global Macular Degeneration Treatment Forecast by Application (2026-2031)
10.7.1 GCC Countries Market Macular Degeneration Treatment Forecast
11 KEY PLAYERS ANALYSIS
11.1 Bausch Health Companies
11.1.1 Bausch Health Companies Company Information
11.1.2 Bausch Health Companies Macular Degeneration Treatment Product Offered
11.1.3 Bausch Health Companies Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.1.4 Bausch Health Companies Main Business Overview
11.1.5 Bausch Health Companies Latest Developments
11.2 Allergan
11.2.1 Allergan Company Information
11.2.2 Allergan Macular Degeneration Treatment Product Offered
11.2.3 Allergan Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.2.4 Allergan Main Business Overview
11.2.5 Allergan Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Macular Degeneration Treatment Product Offered
11.3.3 Novartis Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Macular Degeneration Treatment Product Offered
11.4.3 Pfizer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 Bayer
11.5.1 Bayer Company Information
11.5.2 Bayer Macular Degeneration Treatment Product Offered
11.5.3 Bayer Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.5.4 Bayer Main Business Overview
11.5.5 Bayer Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche Macular Degeneration Treatment Product Offered
11.6.3 Roche Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Sanofi
11.7.1 Sanofi Company Information
11.7.2 Sanofi Macular Degeneration Treatment Product Offered
11.7.3 Sanofi Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.7.4 Sanofi Main Business Overview
11.7.5 Sanofi Latest Developments
11.8 Santen Pharmaceuticals
11.8.1 Santen Pharmaceuticals Company Information
11.8.2 Santen Pharmaceuticals Macular Degeneration Treatment Product Offered
11.8.3 Santen Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.8.4 Santen Pharmaceuticals Main Business Overview
11.8.5 Santen Pharmaceuticals Latest Developments
11.9 Regeneron Pharmaceuticals
11.9.1 Regeneron Pharmaceuticals Company Information
11.9.2 Regeneron Pharmaceuticals Macular Degeneration Treatment Product Offered
11.9.3 Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.9.4 Regeneron Pharmaceuticals Main Business Overview
11.9.5 Regeneron Pharmaceuticals Latest Developments
11.10 Kanghong Pharma
11.10.1 Kanghong Pharma Company Information
11.10.2 Kanghong Pharma Macular Degeneration Treatment Product Offered
11.10.3 Kanghong Pharma Macular Degeneration Treatment Revenue, Gross Margin and Market Share (2020-2025)
11.10.4 Kanghong Pharma Main Business Overview
11.10.5 Kanghong Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Macular Degeneration Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Macular Degeneration Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lucentis
Table 4. Major Players of Eylea
Table 5. Major Players of Avastin
Table 6. Major Players of Others
Table 7. Macular Degeneration Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Table 10. Macular Degeneration Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Macular Degeneration Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Macular Degeneration Treatment Revenue Market Share by Player (2020-2025)
Table 15. Macular Degeneration Treatment Key Players Head office and Products Offered
Table 16. Macular Degeneration Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Macular Degeneration Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Macular Degeneration Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Macular Degeneration Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Macular Degeneration Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Macular Degeneration Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Macular Degeneration Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Macular Degeneration Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Macular Degeneration Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Macular Degeneration Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Macular Degeneration Treatment
Table 41. Key Market Challenges & Risks of Macular Degeneration Treatment
Table 42. Key Industry Trends of Macular Degeneration Treatment
Table 43. Global Macular Degeneration Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Macular Degeneration Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Macular Degeneration Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Macular Degeneration Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Bausch Health Companies Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 48. Bausch Health Companies Macular Degeneration Treatment Product Offered
Table 49. Bausch Health Companies Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Bausch Health Companies Main Business
Table 51. Bausch Health Companies Latest Developments
Table 52. Allergan Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 53. Allergan Macular Degeneration Treatment Product Offered
Table 54. Allergan Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Allergan Main Business
Table 56. Allergan Latest Developments
Table 57. Novartis Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 58. Novartis Macular Degeneration Treatment Product Offered
Table 59. Novartis Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. Pfizer Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 63. Pfizer Macular Degeneration Treatment Product Offered
Table 64. Pfizer Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Pfizer Main Business
Table 66. Pfizer Latest Developments
Table 67. Bayer Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 68. Bayer Macular Degeneration Treatment Product Offered
Table 69. Bayer Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Bayer Main Business
Table 71. Bayer Latest Developments
Table 72. Roche Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 73. Roche Macular Degeneration Treatment Product Offered
Table 74. Roche Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Roche Main Business
Table 76. Roche Latest Developments
Table 77. Sanofi Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 78. Sanofi Macular Degeneration Treatment Product Offered
Table 79. Sanofi Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Santen Pharmaceuticals Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 83. Santen Pharmaceuticals Macular Degeneration Treatment Product Offered
Table 84. Santen Pharmaceuticals Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Santen Pharmaceuticals Main Business
Table 86. Santen Pharmaceuticals Latest Developments
Table 87. Regeneron Pharmaceuticals Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 88. Regeneron Pharmaceuticals Macular Degeneration Treatment Product Offered
Table 89. Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Regeneron Pharmaceuticals Main Business
Table 91. Regeneron Pharmaceuticals Latest Developments
Table 92. Kanghong Pharma Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 93. Kanghong Pharma Macular Degeneration Treatment Product Offered
Table 94. Kanghong Pharma Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Kanghong Pharma Main Business
Table 96. Kanghong Pharma Latest Developments
Table 1. Macular Degeneration Treatment Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Macular Degeneration Treatment Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Lucentis
Table 4. Major Players of Eylea
Table 5. Major Players of Avastin
Table 6. Major Players of Others
Table 7. Macular Degeneration Treatment Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 8. Global Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 9. Global Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Table 10. Macular Degeneration Treatment Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 11. Global Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 12. Global Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Table 13. Global Macular Degeneration Treatment Revenue by Player (2020-2025) & ($ millions)
Table 14. Global Macular Degeneration Treatment Revenue Market Share by Player (2020-2025)
Table 15. Macular Degeneration Treatment Key Players Head office and Products Offered
Table 16. Macular Degeneration Treatment Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Macular Degeneration Treatment Market Size by Region (2020-2025) & ($ millions)
Table 20. Global Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Table 21. Global Macular Degeneration Treatment Revenue by Country/Region (2020-2025) & ($ millions)
Table 22. Global Macular Degeneration Treatment Revenue Market Share by Country/Region (2020-2025)
Table 23. Americas Macular Degeneration Treatment Market Size by Country (2020-2025) & ($ millions)
Table 24. Americas Macular Degeneration Treatment Market Size Market Share by Country (2020-2025)
Table 25. Americas Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 26. Americas Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Table 27. Americas Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 28. Americas Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Table 29. APAC Macular Degeneration Treatment Market Size by Region (2020-2025) & ($ millions)
Table 30. APAC Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Table 31. APAC Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 32. APAC Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 33. Europe Macular Degeneration Treatment Market Size by Country (2020-2025) & ($ millions)
Table 34. Europe Macular Degeneration Treatment Market Size Market Share by Country (2020-2025)
Table 35. Europe Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 36. Europe Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 37. Middle East & Africa Macular Degeneration Treatment Market Size by Region (2020-2025) & ($ millions)
Table 38. Middle East & Africa Macular Degeneration Treatment Market Size by Type (2020-2025) & ($ millions)
Table 39. Middle East & Africa Macular Degeneration Treatment Market Size by Application (2020-2025) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Macular Degeneration Treatment
Table 41. Key Market Challenges & Risks of Macular Degeneration Treatment
Table 42. Key Industry Trends of Macular Degeneration Treatment
Table 43. Global Macular Degeneration Treatment Market Size Forecast by Region (2026-2031) & ($ millions)
Table 44. Global Macular Degeneration Treatment Market Size Market Share Forecast by Region (2026-2031)
Table 45. Global Macular Degeneration Treatment Market Size Forecast by Type (2026-2031) & ($ millions)
Table 46. Global Macular Degeneration Treatment Market Size Forecast by Application (2026-2031) & ($ millions)
Table 47. Bausch Health Companies Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 48. Bausch Health Companies Macular Degeneration Treatment Product Offered
Table 49. Bausch Health Companies Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 50. Bausch Health Companies Main Business
Table 51. Bausch Health Companies Latest Developments
Table 52. Allergan Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 53. Allergan Macular Degeneration Treatment Product Offered
Table 54. Allergan Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 55. Allergan Main Business
Table 56. Allergan Latest Developments
Table 57. Novartis Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 58. Novartis Macular Degeneration Treatment Product Offered
Table 59. Novartis Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 60. Novartis Main Business
Table 61. Novartis Latest Developments
Table 62. Pfizer Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 63. Pfizer Macular Degeneration Treatment Product Offered
Table 64. Pfizer Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 65. Pfizer Main Business
Table 66. Pfizer Latest Developments
Table 67. Bayer Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 68. Bayer Macular Degeneration Treatment Product Offered
Table 69. Bayer Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 70. Bayer Main Business
Table 71. Bayer Latest Developments
Table 72. Roche Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 73. Roche Macular Degeneration Treatment Product Offered
Table 74. Roche Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 75. Roche Main Business
Table 76. Roche Latest Developments
Table 77. Sanofi Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 78. Sanofi Macular Degeneration Treatment Product Offered
Table 79. Sanofi Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 80. Sanofi Main Business
Table 81. Sanofi Latest Developments
Table 82. Santen Pharmaceuticals Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 83. Santen Pharmaceuticals Macular Degeneration Treatment Product Offered
Table 84. Santen Pharmaceuticals Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 85. Santen Pharmaceuticals Main Business
Table 86. Santen Pharmaceuticals Latest Developments
Table 87. Regeneron Pharmaceuticals Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 88. Regeneron Pharmaceuticals Macular Degeneration Treatment Product Offered
Table 89. Regeneron Pharmaceuticals Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 90. Regeneron Pharmaceuticals Main Business
Table 91. Regeneron Pharmaceuticals Latest Developments
Table 92. Kanghong Pharma Details, Company Type, Macular Degeneration Treatment Area Served and Its Competitors
Table 93. Kanghong Pharma Macular Degeneration Treatment Product Offered
Table 94. Kanghong Pharma Macular Degeneration Treatment Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 95. Kanghong Pharma Main Business
Table 96. Kanghong Pharma Latest Developments
LIST OF FIGURES
Figure 1. Macular Degeneration Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Macular Degeneration Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Macular Degeneration Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Macular Degeneration Treatment Sales Market Share by Country/Region (2024)
Figure 8. Macular Degeneration Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Macular Degeneration Treatment Market Size Market Share by Type in 2024
Figure 10. Macular Degeneration Treatment in Hospitals
Figure 11. Global Macular Degeneration Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Macular Degeneration Treatment in Eye Clinics
Figure 13. Global Macular Degeneration Treatment Market: Eye Clinics (2020-2025) & ($ millions)
Figure 14. Macular Degeneration Treatment in Others
Figure 15. Global Macular Degeneration Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Macular Degeneration Treatment Market Size Market Share by Application in 2024
Figure 17. Global Macular Degeneration Treatment Revenue Market Share by Player in 2024
Figure 18. Global Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Macular Degeneration Treatment Value Market Share by Country in 2024
Figure 24. United States Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Macular Degeneration Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Macular Degeneration Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Macular Degeneration Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Macular Degeneration Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 1. Macular Degeneration Treatment Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Macular Degeneration Treatment Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Macular Degeneration Treatment Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Macular Degeneration Treatment Sales Market Share by Country/Region (2024)
Figure 8. Macular Degeneration Treatment Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Macular Degeneration Treatment Market Size Market Share by Type in 2024
Figure 10. Macular Degeneration Treatment in Hospitals
Figure 11. Global Macular Degeneration Treatment Market: Hospitals (2020-2025) & ($ millions)
Figure 12. Macular Degeneration Treatment in Eye Clinics
Figure 13. Global Macular Degeneration Treatment Market: Eye Clinics (2020-2025) & ($ millions)
Figure 14. Macular Degeneration Treatment in Others
Figure 15. Global Macular Degeneration Treatment Market: Others (2020-2025) & ($ millions)
Figure 16. Global Macular Degeneration Treatment Market Size Market Share by Application in 2024
Figure 17. Global Macular Degeneration Treatment Revenue Market Share by Player in 2024
Figure 18. Global Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Figure 19. Americas Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 20. APAC Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 21. Europe Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Macular Degeneration Treatment Market Size 2020-2025 ($ millions)
Figure 23. Americas Macular Degeneration Treatment Value Market Share by Country in 2024
Figure 24. United States Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Macular Degeneration Treatment Market Size Market Share by Region in 2024
Figure 29. APAC Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Figure 30. APAC Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Figure 31. China Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 35. India Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Macular Degeneration Treatment Market Size Market Share by Country in 2024
Figure 38. Europe Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Figure 39. Europe Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Figure 40. Germany Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 41. France Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Macular Degeneration Treatment Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Macular Degeneration Treatment Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Macular Degeneration Treatment Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Macular Degeneration Treatment Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 54. APAC Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 55. Europe Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 57. United States Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 58. Canada Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 59. Mexico Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 60. Brazil Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 61. China Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 62. Japan Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 63. Korea Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 65. India Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 66. Australia Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 67. Germany Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 68. France Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 69. UK Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 70. Italy Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 71. Russia Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 72. Egypt Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 73. South Africa Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 74. Israel Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 75. Turkey Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
Figure 76. Global Macular Degeneration Treatment Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Macular Degeneration Treatment Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Macular Degeneration Treatment Market Size 2026-2031 ($ millions)
